(4) miR-325-3p: Previous studies have shown that miR-325-3p inhibits renal inflammation and fibrosis by targeting C-C motif chemokine ligand 19 (CCL19) [135] and attenuates myocardial fibrosis after myocardial infarction by downregulating GLI-family zinc finger 1 (GLI1) [136]. Here, CCL19 is linked to Myocardial fibrosis.